Stay updated on Zimura vs Sham in STGD1: Clinical Trial
Sign up to get notified when there's something new on the Zimura vs Sham in STGD1: Clinical Trial page.

Latest updates to the Zimura vs Sham in STGD1: Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed build/version marker has been incremented from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site release rather than a study-data update.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded links to the results and plain-language summary on external sites. Updated revision from v3.5.0 to v3.5.2.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Genetic and Rare Diseases Information Center resources entry, including Severe early-childhood-onset retinal dystrophy.SummaryDifference0.1%

- Check39 days agoChange DetectedResults were posted on 2026-03-12 for the study, detailing outcomes such as mean rate of change in the ellipsoid zone defect and changes in BCVA and macular sensitivity through Month 18. The results section also reports adverse events and other safety-related measurements collected up to 18 months.SummaryDifference3%

- Check46 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now shows 'Results Submitted' and removes the 'No Results Posted' notice, and a new revision, v3.4.2, has been published.SummaryDifference0.4%

Stay in the know with updates to Zimura vs Sham in STGD1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura vs Sham in STGD1: Clinical Trial page.